Roles for wbtC, wbtI, and kdtA genes in lipopolysaccharide biosynthesis, protein glycosylation, virulence, and immunogenicity in Francisella tularensis strain SCHU s4

Pathogens

Volumn 1, Issue 1, 2012, Pages 12-29

  Twine, Susan M ^a   Vinogradov, Evguenii ^a   Lindgren, Helena ^b   Sjostedt, Anders ^b   Conlan, J Wayne ^a  

^a NATIONAL RESEARCH COUNCIL CANADA   (Canada)

^b UMEÅ UNIVERSITY   (Sweden)

Author keywords

Francisella tularensis; Glycosylation; Lipopolysaccharide; Virulence

Indexed keywords

KDO TRANSFERASE; LIPOPOLYSACCHARIDE; SUGAR TRANSAMINE PEROSAMINE SYNTHETASE; UNCLASSIFIED DRUG; URIDINE DIPHOSPHATE GLUCOSE 4 EPIMERASE;

ANIMAL EXPERIMENT; ARTICLE; BIOSYNTHESIS; FEMALE; FRANCISELLA TULARENSIS; GAS CHROMATOGRAPHY; GENE; GENE DELETION; HUMAN; IMMUNE RESPONSE; IMMUNOGENICITY; MORPHOLOGY; MOUSE; MUTANT; MUTATION; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN GLYCOSYLATION; SURVIVAL; VIRULENCE; WESTERN BLOTTING;

EID: 84969401651     PISSN: None     EISSN: 20760817     Source Type: Journal    
DOI: 10.3390/pathogens1010012     Document Type: Article

References (43)

1. Sjostedt, A. Tularemia: History, epidemiology, pathogen physiology, and clinical manifestations. Ann. N. Y. Acad. Sci. 2007, 1105, 1-29.
2. Dennis, D.T.; Inglesby, T.V.; Henderson, D.A.; Bartlett, J.G.; Ascher, M.S.; Eitzen, E.; Fine, A.D.; Friedlander, A.M.; Hauer, J.; Layton, M., et al. Tularemia as a biological weapon: Medical and public health management. JAMA 2001, 285, 2763-2773.
3. Kadzhaev, K.; Zingmark, C.; Golovliov, I.; Bolanowski, M.; Shen, H.; Conlan, W.; Sjostedt, A. Identification of genes contributing to the virulence of francisella tularensis schu s4 in a mouse intradermal infection model. PLoS One 2009, 4, e5463.
4. Meibom, K.L.; Charbit, A. The unraveling panoply of francisella tularensis virulence attributes. Curr. Opin. Microbiol. 2010, 13, 11-17.
5. Vinogradov, E.; Conlan, W.J.; Gunn, J.S.; Perry, M.B. Characterization of the lipopolysaccharide o-antigen of francisella novicida (u112). Carbohydr. Res. 2004, 339, 649-654.
6. Conlan, J.W.; Shen, H.; Webb, A.; Perry, M.B. Mice vaccinated with the o-antigen of francisella tularensis lvs lipopolysaccharide conjugated to bovine serum albumin develop varying degrees of protective immunity against systemic or aerosol challenge with virulent type a and type b strains of the pathogen. Vaccine 2002, 20, 3465-3471.
7. Kim, T.H.; Sebastian, S.; Pinkham, J.T.; Ross, R.A.; Blalock, L.T.; Kasper, D.L. Characterization of the o-antigen polymerase (wzy) of francisella tularensis. J. Biol. Chem. 2010, 285, 27839-27849.
8. Thomas, R.M.; Titball, R.W.; Oyston, P.C.; Griffin, K.; Waters, E.; Hitchen, P.G.; Michell, S.L.; Grice, I.D.; Wilson, J.C.; Prior, J.L. The immunologically distinct o antigens from francisella tularensis subspecies tularensis and francisella novicida are both virulence determinants and protective antigens. Infect. Immun. 2007, 75, 371-378.
9. Prior, J.L.; Prior, R.G.; Hitchen, P.G.; Diaper, H.; Griffin, K.F.; Morris, H.R.; Dell, A.; Titball, R.W. Characterization of the o antigen gene cluster and structural analysis of the o antigen of francisella tularensis subsp. Tularensis. J. Med. Microbiol. 2003, 52, 845-851.
10. Hartley, G.; Taylor, R.; Prior, J.; Newstead, S.; Hitchen, P.G.; Morris, H.R.; Dell, A.; Titball, R.W. Grey variants of the live vaccine strain of francisella tularensis lack lipopolysaccharide o-antigen, show reduced ability to survive in macrophages and do not induce protective immunity in mice. Vaccine 2006, 24, 989-996.
11. Li, J.; Ryder, C.; Mandal, M.; Ahmed, F.; Azadi, P.; Snyder, D.S.; Pechous, R.D.; Zahrt, T.; Inzana, T.J. Attenuation and protective efficacy of an o-antigen-deficient mutant of francisella tularensis lvs. Microbiology 2007, 153, 3141-3153.
12. Raynaud, C.; Meibom, K.L.; Lety, M.A.; Dubail, I.; Candela, T.; Frapy, E.; Charbit, A. Role of the wbt locus of francisella tularensis in lipopolysaccharide o-antigen biogenesis and pathogenicity. Infect. Immun. 2007, 75, 536-541.
13. Maier, T.M.; Casey, M.S.; Becker, R.H.; Dorsey, C.W.; Glass, E.M.; Maltsev, N.; Zahrt, T.C.; Frank, D.W. Identification of francisella tularensis himar1-based transposon mutants defective for replication in macrophages. Infect. Immun. 2007, 75, 5376-5389.
14. Sebastian, S.; Dillon, S.T.; Lynch, J.G.; Blalock, L.T.; Balon, E.; Lee, K.T.; Comstock, L.E.; Conlan, J.W.; Rubin, E.J.; Tzianabos, A.O., et al. A defined o-antigen polysaccharide mutant of francisella tularensis live vaccine strain has attenuated virulence while retaining its protective capacity. Infect. Immun. 2007, 75, 2591-2602.
15. Raetz, C.R.; Reynolds, C.M.; Trent, M.S.; Bishop, R.E. Lipid a modification systems in gram-negative bacteria. Annu. Rev. Biochem. 2007, 76, 295-329.
16. Vinogradov, E.; Perry, M.B.; Conlan, J.W. Structural analysis of francisella tularensis lipopolysaccharide. Eur. J. Biochem. 2002, 269, 6112-6118.
17. Schoenhofen, I.C.; McNally, D.J.; Vinogradov, E.; Whitfield, D.; Young, N.M.; Dick, S.; Wakarchuk, W.W.; Brisson, J.R.; Logan, S.M. Functional characterization of dehydratase/ aminotransferase pairs from helicobacter and campylobacter: Enzymes distinguishing the pseudaminic acid and bacillosamine biosynthetic pathways. J. Biol. Chem. 2006, 281, 723-732.
18. Sebastian, S.; Pinkham, J.T.; Lynch, J.G.; Ross, R.A.; Reinap, B.; Blalock, L.T.; Conlan, J.W.; Kasper, D.L. Cellular and humoral immunity are synergistic in protection against types a and b francisella tularensis. Vaccine 2009, 27, 597-605.
19. Thomas, R.M.; Twine, S.M.; Fulton, K.M.; Tessier, L.; Kilmury, S.L.; Ding, W.; Harmer, N.; Michell, S.L.; Oyston, P.C.; Titball, R.W., et al. Glycosylation of dsba in francisella tularensis subsp. Tularensis. J. Bacteriol. 2011, 193, 5498-5509.
20. Egge-Jacobsen, W.; Salomonsson, E.N.; Aas, F.E.; Forslund, A.L.; Winther-Larsen, H.C.; Maier, J.; Macellaro, A.; Kuoppa, K.; Oyston, P.C.; Titball, R.W., et al. O-linked glycosylation of the pila pilin protein of francisella tularensis: Identification of the endogenous protein-targeting oligosaccharyltransferase and characterization of the native oligosaccharide. J. Bacteriol. 2011, 193, 5487-5497.
21. Balonova, L.; Hernychova, L.; Mann, B.F.; Link, M.; Bilkova, Z.; Novotny, M.V.; Stulik, J. Multimethodological approach to identification of glycoproteins from the proteome of francisella tularensis, an intracellular microorganism. J. Proteome Res. 2010, 9, 1995-2005.
22. Knirel, Y.A.; Skvortsov, I.M.; Shashkov, A.S.; Dmitriev, B.A.; Kochetkov, N.K.; Stanislavsky, E.S.; Mashilova, G.M. Somatic antigens of pseudomonas aeruginosa. The structure of the o-specific polysaccharide chains of p. Aeruginosa o11 (lanyi) lipopolysaccharides. Eur. J. Biochem. 1985, 150, 551-557.
23. Belanger, M.; Burrows, L.L.; Lam, J.S. Functional analysis of genes responsible for the synthesis of the b-band o antigen of pseudomonas aeruginosa serotype o6 lipopolysaccharide. Microbiology 1999, 145 (Pt 12), 3505-3521.
24. Wyk, P.; Reeves, P. Identification and sequence of the gene for abequose synthase, which confers antigenic specificity on group b salmonellae: Homology with galactose epimerase. J. Bacteriol. 1989, 171, 5687-5693.
25. Apicella, M.A.; Post, D.M.; Fowler, A.C.; Jones, B.D.; Rasmussen, J.A.; Hunt, J.R.; Imagawa, S.; Choudhury, B.; Inzana, T.J.; Maier, T.M., et al. Identification, characterization and immunogenicity of an o-antigen capsular polysaccharide of francisella tularensis. PLoS One 2010, 5, e11060.
26. Forsberg, L.S.; Noel, K.D.; Box, J.; Carlson, R.W. Genetic locus and structural characterization of the biochemical defect in the o-antigenic polysaccharide of the symbiotically deficient rhizobium etli mutant, ce166. Replacement of n-acetylquinovosamine with its hexosyl-4-ulose precursor. J. Biol. Chem. 2003, 278, 51347-51359.
27. Balonova, L.; Mann, B.F.; Cerveny, L.; Alley, W.R.; Chovancova, E.; Forslund, A.L.; Salomonsson, E.N.; Forsberg, A.; Damborsky, J.; Novotny, M.V., et al. Characterization of protein glycosylation in francisella tularensis subsp. Holarctica; identification of a novel glycosylated lipoprotein required for virulence. Mol. Cell Proteomics 2012, 11, M111.015016.
28. Qin, A.; Scott, D.W.; Thompson, J.A.; Mann, B.J. Identification of an essential francisella tularensis subsp. Tularensis virulence factor. Infect. Immun. 2009, 77, 152-161.
29. Castric, P.; Cassels, F.J.; Carlson, R.W. Structural characterization of the pseudomonas aeruginosa 1244 pilin glycan. J. Biol. Chem. 2001, 276, 26479-26485.
30. Tabei, S.M.; Hitchen, P.G.; Day-Williams, M.J.; Merino, S.; Vart, R.; Pang, P.C.; Horsburgh, G.J.; Viches, S.; Wilhelms, M.; Tomas, J.M., et al. An aeromonas caviae genomic island is required for both o-antigen lipopolysaccharide biosynthesis and flagellin glycosylation. J. Bacteriol. 2009, 191, 2851-2863.
31. Hug, I.; Couturier, M.R.; Rooker, M.M.; Taylor, D.E.; Stein, M.; Feldman, M.F. Helicobacter pylori lipopolysaccharide is synthesized via a novel pathway with an evolutionary connection to protein n-glycosylation. PLoS Pathog. 2010, 6, e1000819.
32. Cullen, T.W.; Trent, M.S. A link between the assembly of flagella and lipooligosaccharide of the gram-negative bacterium campylobacter jejuni. Proc. Natl. Acad. Sci. USA 2010, 107, 5160-5165.
33. Clementz, T. The gene coding for 3-deoxy-manno-octulosonic acid transferase and the rfaq gene are transcribed from divergently arranged promoters in escherichia coli. J. Bacteriol. 1992, 174, 7750-7756.
34. Sorokin, V.M.; Pavlovich, N.V.; Prozorova, L.A. Francisella tularensis resistance to bactericidal action of normal human serum. FEMS Immunol. Med. Microbiol. 1996, 13, 249-252.
35. Clay, C.D.; Soni, S.; Gunn, J.S.; Schlesinger, L.S. Evasion of complement-mediated lysis and complement c3 deposition are regulated by francisella tularensis lipopolysaccharide o antigen. J. Immunol. 2008, 181, 5568-5578.
36. Sandstrom, G.; Lofgren, S.; Tarnvik, A. A capsule-deficient mutant of francisella tularensis lvs exhibits enhanced sensitivity to killing by serum but diminished sensitivity to killing by polymorphonuclear leukocytes. Infect. Immun. 1988, 56, 1194-1202.
37. Eigelsbach, H.T.; Braun, W.; Herring, R.D. Studies on the variation of bacterium tularense. J. Bacteriol. 1951, 61, 557-569.
38. Baker, C.N.; Hollis, D.G.; Thornsberry, C. Antimicrobial susceptibility testing of francisella tularensis with a modified mueller-hinton broth. J. Clin. Microbiol. 1985, 22, 212-215.
39. Twine, S.M.; Petit, M.D.; Fulton, K.M.; House, R.V.; Conlan, J.W. Immunoproteomics analysis of the murine antibody response to vaccination with an improved francisella tularensis live vaccine strain (lvs). PLoS One 2010, 5, e10000.
40. Twine, S.M.; Mykytczuk, N.C.; Petit, M.; Tremblay, T.L.; Lanthier, P.; Conlan, J.W.; Kelly, J.F. Francisella tularensis proteome: Low levels of asb-14 facilitate the visualization of membrane proteins in total protein extracts. J. Proteome Res. 2005, 4, 1848-1854.
41. Twine, S.M.; Reid, C.W.; Aubry, A.; McMullin, D.R.; Fulton, K.M.; Austin, J.; Logan, S.M. Motility and flagellar glycosylation in clostridium difficile. J Bacteriol. 2009, 191, 7050-7062.
42. Conlan, J.W.; Chen, W.; Shen, H.; Webb, A.; KuoLee, R. Experimental tularemia in mice challenged by aerosol or intradermally with virulent strains of francisella tularensis: Bacteriologic and histopathologic studies. Microb. Pathog. 2003, 34, 239-248.
43. Chamberlain, R.E. Evaluation of live tularemia vaccine prepared in a chemically defined medium.